Home › Funds › C WorldWide Group Holding A/S › KRYS

C WorldWide Group Holding A/S position in KRYS

KRYSTAL BIOTECH INC · Health Care

C WorldWide Group Holding A/S reported holding 57,809 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$19.2M, representing 0.49% of its reported portfolio and ranking #34 among its reported holdings. C WorldWide Group Holding A/S has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)57.81K sh
Reported value held$19.23M
Portfolio Weight0.49%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How C WorldWide Group Holding A/S's KRYS position evolved

C WorldWide Group Holding A/S first disclosed a stake in KRYS in Q3 2023 at 185,809 shares (US$21.6M). The position peaked in Q2 2024 at 135,809 shares, worth US$24.9M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 57,809 shares valued at US$19.2M. Notable position changes include a 27% trim in Q1 2024 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 185.81K $21.55M New
Q4 2023 185.81K $23.05M Hold
Q1 2024 135.81K $24.16M Reduce
Q2 2024 135.81K $24.94M Hold
Q3 2024 135.81K $24.72M Hold
Q4 2024 105.81K $16.58M Reduce
Q1 2025 85.81K $15.47M Reduce
Q2 2025 85.81K $11.79M Hold
Q3 2025 85.81K $15.15M Hold
Q4 2025 85.81K $21.16M Hold
Q1 2026 67.81K $17.52M Reduce
Q2 2026 57.81K $21.49M Reduce
Q3 2026 57.81K $19.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 42 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has C WorldWide Group Holding A/S held KRYS?

C WorldWide Group Holding A/S has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is C WorldWide Group Holding A/S's current position in KRYS?

As of Q3 2026, C WorldWide Group Holding A/S holds 57.81K shares of KRYS (KRYSTAL BIOTECH INC), valued at $19.23M, representing 0.49% of its reported portfolio and ranking #34.

Has C WorldWide Group Holding A/S been buying or selling KRYS?

In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in KRYS. The position peaked in Q2 2024 at 135.81K shares.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.